Arthritic joint-targeting small interfering RNA-encapsulated liposome: implication for treatment strategy for rheumatoid arthritis
- PMID: 21994423
- DOI: 10.1124/jpet.111.185884
Arthritic joint-targeting small interfering RNA-encapsulated liposome: implication for treatment strategy for rheumatoid arthritis
Abstract
RNA interference, mediated by small interfering RNA (siRNA), is effective in silencing genes with a high degree of specificity. To explore the therapeutic potential of systemically administered siRNA for rheumatoid arthritis (RA), we tested the complex of siRNA and the recently developed wrapsome (siRNA/WS) containing siRNA-encapsulated liposome in mice with collagen-induced arthritis (CIA). Mice with CIA received an intravenous injection of Cy5-labeled siRNA/WS. Fluorescence stereoscopic microscopy and flow cytometry were used to assess the siRNA/WS tissue distribution. The efficacy of siRNA-targeting tumor necrosis factor (TNF)-α/WS in CIA was evaluated by arthritis score. TNF-α mRNA levels in the joints were measured by real-time reverse transcriptase-polymerase chain reaction. The intensity of Cy5 fluorescence was higher in arthritic joints than in nonarthritic sites in Cy5-siRNA/WS-treated mice and remained higher up to 48 h after injection, compared with that in naked Cy5-siRNA-treated mice. Cy5 fluorescence intensity was higher in synovial cells than in splenocytes, bone marrow cells, and peripheral blood leukocytes. The majority of Cy5-positive synovial cells were CD11b⁺ with only a few CD3⁺ cells. Treatment with TNF-α siRNA/WS resulted in significant decreases in severity of arthritis and TNF-α mRNA level in the joints compared with control siRNA/WS. In conclusion, the use of our WS allowed efficient and targeted delivery of siRNAs to arthritic joints. The siRNA/WS was mainly incorporated into CD11b⁺ cells, including macrophages and neutrophils, in the inflamed synovium, suggesting its potential therapeutic effects in RA by silencing the expression of inflammatory molecules produced by these cells.
Similar articles
-
Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.Arthritis Rheum. 2005 Apr;52(4):1314-8. doi: 10.1002/art.20975. Arthritis Rheum. 2005. PMID: 15818667
-
Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.Arthritis Rheum. 2008 Aug;58(8):2356-67. doi: 10.1002/art.23660. Arthritis Rheum. 2008. PMID: 18668557
-
Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.Arthritis Rheum. 2006 Jun;54(6):1867-77. doi: 10.1002/art.21876. Arthritis Rheum. 2006. PMID: 16729293
-
Targeting monocytes/macrophages in the treatment of rheumatoid arthritis.Rheumatology (Oxford). 2013 Apr;52(4):590-8. doi: 10.1093/rheumatology/kes304. Epub 2012 Nov 30. Rheumatology (Oxford). 2013. PMID: 23204551 Review.
-
Real-time quantification of antibody-short interfering RNA conjugate in serum by antigen capture reverse transcription-polymerase chain reaction.Anal Biochem. 2012 Nov 15;430(2):171-8. doi: 10.1016/j.ab.2012.08.018. Epub 2012 Aug 26. Anal Biochem. 2012. PMID: 22929697 Review.
Cited by
-
The emerging potential of siRNA nanotherapeutics in treatment of arthritis.Asian J Pharm Sci. 2023 Sep;18(5):100845. doi: 10.1016/j.ajps.2023.100845. Epub 2023 Sep 16. Asian J Pharm Sci. 2023. PMID: 37881798 Free PMC article. Review.
-
Research Advances in Nucleic Acid Delivery System for Rheumatoid Arthritis Therapy.Pharmaceutics. 2023 Apr 13;15(4):1237. doi: 10.3390/pharmaceutics15041237. Pharmaceutics. 2023. PMID: 37111722 Free PMC article. Review.
-
Recent advances in nanoparticle-based drug delivery systems for rheumatoid arthritis treatment.Nanoscale Adv. 2022 Jul 26;4(17):3479-3494. doi: 10.1039/d2na00229a. eCollection 2022 Aug 23. Nanoscale Adv. 2022. PMID: 36134349 Free PMC article. Review.
-
Recent Advances in Liposomal-Based Anti-Inflammatory Therapy.Pharmaceutics. 2021 Jul 1;13(7):1004. doi: 10.3390/pharmaceutics13071004. Pharmaceutics. 2021. PMID: 34371695 Free PMC article. Review.
-
Food-Derived Nanoscopic Drug Delivery Systems for Treatment of Rheumatoid Arthritis.Molecules. 2020 Jul 31;25(15):3506. doi: 10.3390/molecules25153506. Molecules. 2020. PMID: 32752061 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials